In this episode of the SHEA Podcast, host Dr. Jonathan Ryder moderates a lively pro/con debate on one of the most discussed biomarkers in infectious diseases: procalcitonin.
Joining the conversation are two experts with distinct perspectives: Dr. Michael Mansour, Clinician Investigator and Associate Professor of Infectious Diseases at Massachusetts General Hospital and Harvard Medical School, and Dr. Sheetal Kandiah, Senior Physician and Assistant Clinical Professor of Medicine in the Division of Infectious Diseases at Emory University; Director of the Antibiotic Stewardship Program at Grady Hospital.
Together, they explore where PCT may (or may not) add value in antimicrobial stewardship programs. Tune in for an insightful exchange that will help stewards, clinicians, and ID professionals better understand where PCT fits into today’s rapidly evolving diagnostic landscape.
All content for The SHEA Podcast is the property of The SHEA Podcast and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of the SHEA Podcast, host Dr. Jonathan Ryder moderates a lively pro/con debate on one of the most discussed biomarkers in infectious diseases: procalcitonin.
Joining the conversation are two experts with distinct perspectives: Dr. Michael Mansour, Clinician Investigator and Associate Professor of Infectious Diseases at Massachusetts General Hospital and Harvard Medical School, and Dr. Sheetal Kandiah, Senior Physician and Assistant Clinical Professor of Medicine in the Division of Infectious Diseases at Emory University; Director of the Antibiotic Stewardship Program at Grady Hospital.
Together, they explore where PCT may (or may not) add value in antimicrobial stewardship programs. Tune in for an insightful exchange that will help stewards, clinicians, and ID professionals better understand where PCT fits into today’s rapidly evolving diagnostic landscape.
A Conversation with SHEA 2025 President David J. Weber
The SHEA Podcast
9 minutes 22 seconds
1 year ago
A Conversation with SHEA 2025 President David J. Weber
In this episode of The SHEA Podcast, Past President Dr. Tom Talbot sits down with SHEA’s 2025 President, Dr. David J. Weber, to discuss his inspiring journey in the field of infection prevention and control. Together, they discuss Dr. Weber’s background, his career path, and the experiences that shaped him as a leader. Dr. Weber also shares his perspective on balancing a demanding career, volunteer commitments to SHEA, and personal responsibilities. Finally, he outlines his vision for SHEA during his presidential year, focusing on fostering inclusivity, advancing the implementation of effective practices, and promoting the dissemination of evidence-based scientific knowledge to improve healthcare outcomes.
The SHEA Podcast
In this episode of the SHEA Podcast, host Dr. Jonathan Ryder moderates a lively pro/con debate on one of the most discussed biomarkers in infectious diseases: procalcitonin.
Joining the conversation are two experts with distinct perspectives: Dr. Michael Mansour, Clinician Investigator and Associate Professor of Infectious Diseases at Massachusetts General Hospital and Harvard Medical School, and Dr. Sheetal Kandiah, Senior Physician and Assistant Clinical Professor of Medicine in the Division of Infectious Diseases at Emory University; Director of the Antibiotic Stewardship Program at Grady Hospital.
Together, they explore where PCT may (or may not) add value in antimicrobial stewardship programs. Tune in for an insightful exchange that will help stewards, clinicians, and ID professionals better understand where PCT fits into today’s rapidly evolving diagnostic landscape.
